We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -1.76056338028 | 2.84 | 3.3 | 2.61 | 1779 | 2.82005293 | CS |
4 | 0.18 | 6.89655172414 | 2.61 | 3.3 | 2.6 | 5554 | 2.82681292 | CS |
12 | 0.31 | 12.5 | 2.48 | 3.3 | 2.4 | 5778 | 2.7114414 | CS |
26 | 0.13 | 4.88721804511 | 2.66 | 3.3 | 1.87 | 10359 | 2.36340268 | CS |
52 | -0.11 | -3.79310344828 | 2.9 | 4.05 | 1.62 | 9483 | 2.49155461 | CS |
156 | -4.59 | -62.1951219512 | 7.38 | 9.33 | 1.62 | 10440 | 4.62590547 | CS |
260 | -4.59 | -62.1951219512 | 7.38 | 9.33 | 1.62 | 10440 | 4.62590547 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions